ArticleCancer science2021

Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer.

Seiji Hoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.